Prophylaxis of venous thromboembolism in abdominal wall surgery

Hernia

Volumn 4, Issue 4, 2000, Pages 242-247

  Hidalgo, M ^a   Figueroa, J M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Hernia; Low molecular weight heparin (LMWH); Thromboembolism prophylaxis

Indexed keywords

BEMIPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ABDOMINAL SURGERY; ADULT; AGED; ALLERGIC REACTION; CLINICAL OBSERVATION; CLINICAL TRIAL; CONFERENCE PAPER; DIAPHRAGM EVENTRATION; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; FEMALE; HEMATOMA; HERNIA; HERNIORRHAPHY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0034521848     PISSN: 12654906     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01201075     Document Type: Article

References (30)

1. Applying risk assessment models in general surgery: Overview of our clinical experience
2. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 vs. 5000 XaI units in 2070 patients
3. Low molecular weight heparin therapy: Is monitoring needed?
4. Low molecular weight heparins in the prevention of deep-vein thrombosis in general surgery
5. Clinical assessment of venous thromboembolic risk in surgical patients
6. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis
7. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic and urologic surgery
8. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge
9. Heparin-induced thrombocytopenia
10. Potentials risks in drug prevention of thrombosis-low-molecular-weight heparin versus standard heparin
11. Chemical structure-activity ratio of the low molecular weight heparins (HBPM). Towards a second generation of Low Molecular Weight Heparins?
12. Venous thromboembolism after total hip or knee arthroplasty: A survey of Canadian orthopedic surgeons
13. Low molecular weight heparin
14. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis
15. Randomized, controlled trial of low molecular weight heparin vs. No deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients
16. Low molecular weight heparin and prevention of postoperative deep vein thrombosis
17. Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial
18. A Comparative, Double-blind, Randomised Trial of a New Second Generation LMWH (Bemiparin) and UFH in the Prevention of Post-operative Venous Thromboembolism in Patients Undergoing Hip arthroplasty
19. Perioperative prophylaxis of venous thromboembolism
20. Deep-vein thrombosis prophylaxis in orthopedic surgery: Hip surgery
21. Incidence and prevention of deep venous thrombosis occurring late after general surgery: Randomised controlled study of prolonged thromboprophylaxis
22. Comparison of the efficacy and safety of low molecular weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis. An update meta-analysis
23. Risk and prophylaxis for venous thromboembolism in hospital patients
24. Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery
25. Low-molecular-weight heparin versus standard heparin in general orthopaedic surgery: A meta-analysis
26. Comparison of two low-molecular-weight heparins for the prevention of post-operative venous thromboembolism after elective hip surgery. Reviparin Study Group
27. Prevention of deep vein thrombosis after hip replacement: Comparison between two low-molecular heparins, tinzaparin and enoxaparin
28. Epidural haematoma in an ambulatory surgical patient
29. Applying risk assessment models in general surgery: Effective risk stratification
30. Low-molecular-weight heparins